| Style | Citing Format |
|---|---|
| MLA | Soltanghoraee H, et al.. "Histological Evaluation of Products of Conception, Who Benefits From It?." Fetal and Pediatric Pathology, vol. 42, no. 1, 2023, pp. 30-43. |
| APA | Soltanghoraee H, Mohazzab A, Soltani A, Ansaripour S, Tavakoli M, Rafati M, Zarnani AH, Ghaffari SR (2023). Histological Evaluation of Products of Conception, Who Benefits From It?. Fetal and Pediatric Pathology, 42(1), 30-43. |
| Chicago | Soltanghoraee H, Mohazzab A, Soltani A, Ansaripour S, Tavakoli M, Rafati M, Zarnani AH, Ghaffari SR. "Histological Evaluation of Products of Conception, Who Benefits From It?." Fetal and Pediatric Pathology 42, no. 1 (2023): 30-43. |
| Harvard | Soltanghoraee H et al. (2023) 'Histological Evaluation of Products of Conception, Who Benefits From It?', Fetal and Pediatric Pathology, 42(1), pp. 30-43. |
| Vancouver | Soltanghoraee H, Mohazzab A, Soltani A, Ansaripour S, Tavakoli M, Rafati M, et al.. Histological Evaluation of Products of Conception, Who Benefits From It?. Fetal and Pediatric Pathology. 2023;42(1):30-43. |
| BibTex | @article{ author = {Soltanghoraee H and Mohazzab A and Soltani A and Ansaripour S and Tavakoli M and Rafati M and Zarnani AH and Ghaffari SR}, title = {Histological Evaluation of Products of Conception, Who Benefits From It?}, journal = {Fetal and Pediatric Pathology}, volume = {42}, number = {1}, pages = {30-43}, year = {2023} } |
| RIS | TY - JOUR AU - Soltanghoraee H AU - Mohazzab A AU - Soltani A AU - Ansaripour S AU - Tavakoli M AU - Rafati M AU - Zarnani AH AU - Ghaffari SR TI - Histological Evaluation of Products of Conception, Who Benefits From It? JO - Fetal and Pediatric Pathology VL - 42 IS - 1 SP - 30 EP - 43 PY - 2023 ER - |